Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Gynecol Oncol. 2020 Feb 24;157(2):437–443. doi: 10.1016/j.ygyno.2020.02.017

Table 1.

Multivariate analysis of overall survival.

Factors OS
HR (95% CI) P-value*
Age 1.01 (0.98 – 1.04) 0.485
Stage (III/IV vs II) 1.67 (0.83 – 3.39) 0.154
Tumor size 0.83 (0.68 – 1.03) 0.091
SCC-Antigen 1.00 (0.99 – 1.00) 0.725
Early CR 0.28 (0.11 – 0.74) 0.010
RS 2.07 (1.71 – 2.50) <0.001

Abbreviations: HR, hazard ratio; CR, complete response; RS, risk score; CI, confidential interval; PFS, progression-free survival; OS overall survival Significant P-values in bold.

*

Cox proportional hazard analysis